These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11255297)

  • 1. Current practices in transfusion medicine.
    Borker A; Warrier RP
    Indian Pediatr; 2001 Mar; 38(3):227-30. PubMed ID: 11255297
    [No Abstract]   [Full Text] [Related]  

  • 2. [Developments in blood transfusion].
    Krusius T; Porkka K
    Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evolution of the practices of labile blood product distribution].
    Tardivel R
    Transfus Clin Biol; 2005 Jun; 12(2):177-9. PubMed ID: 15894509
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transfusion and its specific problems in pediatrics and neonatology].
    Pérel Y; Runel C; Huguenin Y; Renesme L; Aladjidi N
    Transfus Clin Biol; 2017 Sep; 24(3):101-105. PubMed ID: 28709844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood transfusion safety].
    Koistinen J
    Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
    [No Abstract]   [Full Text] [Related]  

  • 6. [Special features of blood transfusion to children].
    Salonvaara M
    Duodecim; 2004; 120(7):860-5. PubMed ID: 15154307
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for assessing appropriateness of pediatric transfusion.
    Roseff SD; Luban NL; Manno CS
    Transfusion; 2002 Nov; 42(11):1398-413. PubMed ID: 12421212
    [No Abstract]   [Full Text] [Related]  

  • 8. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy].
    Heim MU
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of transfusion triggers for red blood cell concentrates.
    Hardy JF
    Transfus Apher Sci; 2004 Aug; 31(1):55-66. PubMed ID: 15294196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The problems of modern transfusion science].
    Vorob'ev AI; Dabberkha NM
    Ter Arkh; 1991; 63(7):4-9. PubMed ID: 1788805
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products].
    Gouëzec H; Jego P; Bétrémieux P; Nimubona S; Grulois I
    Transfus Clin Biol; 2005 Jun; 12(2):169-76. PubMed ID: 15894502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicians as gatekeepers: what is the best route to optimal blood use?
    Isbister JP
    Dev Biol (Basel); 2007; 127():9-14. PubMed ID: 17486878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An appraisal of pediatric dermatological emergencies.
    Sarkar R; Basu S; Patwari AK; Sharma RC; Dutta AK; Sardana K
    Indian Pediatr; 2000 Apr; 37(4):425-9. PubMed ID: 10781239
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for administration of blood products: transfusion of infants and neonates. British Committee for Standards in Haematology Blood Transfusion Task Force.
    Voak D; Cann R; Finney RD; Fraser ID; Mitchell R; Murphy MF; Napier JA; Phillips P; Rejman AJ; Waters AH
    Transfus Med; 1994 Mar; 4(1):63-9. PubMed ID: 8012495
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric anesthesia--potential risks and their assessment: part II.
    von Ungern-Sternberg BS; Habre W
    Paediatr Anaesth; 2007 Apr; 17(4):311-20. PubMed ID: 17359398
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion support to Dengue patients in a hospital based blood transfusion service in north India.
    Chaudhary R; Khetan D; Sinha S; Sinha P; Sonker A; Pandey P; Das SS; Agarwal P; Ray V
    Transfus Apher Sci; 2006 Dec; 35(3):239-44. PubMed ID: 17097349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusion policy among European pediatric intensive care physicians.
    Nahum E; Ben-Ari J; Schonfeld T
    J Intensive Care Med; 2004; 19(1):38-43. PubMed ID: 15035753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and procedure-specific survival among transfusion of recipients in 1993 and 2000, Orebro County, Sweden.
    Tynell E; Norda R; Montgomery SM; Björkman A
    Vox Sang; 2005 Apr; 88(3):181-8. PubMed ID: 15787728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer incidence in blood transfusion recipients.
    Hjalgrim H; Edgren G; Rostgaard K; Reilly M; Tran TN; Titlestad KE; Shanwell A; Jersild C; Adami J; Wikman A; Gridley G; Wideroff L; Nyrén O; Melbye M
    J Natl Cancer Inst; 2007 Dec; 99(24):1864-74. PubMed ID: 18073377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood transfusion strategy in pediatrics.
    Saldien V
    Acta Anaesthesiol Belg; 2003; 54(4):303. PubMed ID: 14719350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.